IN2014MN01989A - - Google Patents
Info
- Publication number
- IN2014MN01989A IN2014MN01989A IN1989MUN2014A IN2014MN01989A IN 2014MN01989 A IN2014MN01989 A IN 2014MN01989A IN 1989MUN2014 A IN1989MUN2014 A IN 1989MUN2014A IN 2014MN01989 A IN2014MN01989 A IN 2014MN01989A
- Authority
- IN
- India
- Prior art keywords
- hepatitis
- treatment
- determining whether
- sample
- methods
- Prior art date
Links
- 208000002672 hepatitis B Diseases 0.000 abstract 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000003491 array Methods 0.000 abstract 1
- 229960004203 carnitine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/131—Allele specific probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12160199 | 2012-03-19 | ||
| EP12186188 | 2012-09-26 | ||
| PCT/NL2013/050204 WO2013141705A2 (en) | 2012-03-19 | 2013-03-19 | Means and methods for response prediction of hepatitis b treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01989A true IN2014MN01989A (enExample) | 2015-07-10 |
Family
ID=47997743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1989MUN2014 IN2014MN01989A (enExample) | 2012-03-19 | 2013-03-19 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20150044167A1 (enExample) |
| EP (1) | EP2828401B1 (enExample) |
| BR (1) | BR112014023296A2 (enExample) |
| ES (1) | ES2657266T3 (enExample) |
| HK (1) | HK1206791A1 (enExample) |
| IN (1) | IN2014MN01989A (enExample) |
| MX (1) | MX2014011256A (enExample) |
| RU (1) | RU2640256C2 (enExample) |
| WO (1) | WO2013141705A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105829548A (zh) * | 2013-12-17 | 2016-08-03 | 豪夫迈·罗氏有限公司 | 用于hbv治疗反应的生物标记物 |
| EP3322820A1 (en) * | 2015-07-15 | 2018-05-23 | H. Hoffnabb-La Roche Ag | Biomarkers for hbv treatment response |
| CN109504763B (zh) * | 2018-12-17 | 2020-09-04 | 北京三元基因药业股份有限公司 | 用于预测α干扰素治疗乙肝患者疗效的分子标记 |
| UA129589C2 (uk) | 2018-12-19 | 2025-06-11 | Лео Фарма А/С | Аніліди амінокислот як низькомолекулярні модулятори il-17 |
| CN115267193B (zh) * | 2022-09-20 | 2022-12-27 | 北京大学 | 用于判断生物样本中HBsAg来源的方法及系统和用途 |
-
2013
- 2013-03-19 EP EP13712387.3A patent/EP2828401B1/en not_active Not-in-force
- 2013-03-19 HK HK15107184.4A patent/HK1206791A1/xx unknown
- 2013-03-19 US US14/386,176 patent/US20150044167A1/en not_active Abandoned
- 2013-03-19 MX MX2014011256A patent/MX2014011256A/es unknown
- 2013-03-19 BR BR112014023296A patent/BR112014023296A2/pt not_active IP Right Cessation
- 2013-03-19 WO PCT/NL2013/050204 patent/WO2013141705A2/en not_active Ceased
- 2013-03-19 IN IN1989MUN2014 patent/IN2014MN01989A/en unknown
- 2013-03-19 RU RU2014142009A patent/RU2640256C2/ru not_active IP Right Cessation
- 2013-03-19 ES ES13712387.3T patent/ES2657266T3/es active Active
-
2017
- 2017-08-29 US US15/689,582 patent/US20180044735A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1206791A1 (en) | 2016-01-15 |
| MX2014011256A (es) | 2015-07-14 |
| US20150044167A1 (en) | 2015-02-12 |
| WO2013141705A3 (en) | 2013-12-05 |
| BR112014023296A2 (pt) | 2019-09-24 |
| US20180044735A1 (en) | 2018-02-15 |
| RU2014142009A (ru) | 2016-05-10 |
| ES2657266T3 (es) | 2018-03-02 |
| EP2828401A2 (en) | 2015-01-28 |
| EP2828401B1 (en) | 2017-10-25 |
| WO2013141705A2 (en) | 2013-09-26 |
| RU2640256C2 (ru) | 2017-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015011435A (es) | Amplificación de ácidos nucléicos. | |
| MX2016007541A (es) | Moléculas modificadas de ácido nucleico y usos de las mismas. | |
| GB2537077A (en) | Methods for sequencing nucleic acids | |
| MX381592B (es) | Composiciones de detergente, variantes de lipasa y polinucleotidos que codifican las mismas. | |
| MX354267B (es) | Nucléosidos, nucleótidos, y ácidos nucleicos modificados, y usos de los mismos. | |
| ES2935860T5 (en) | Spatially distinguished, multiplex nucleic acid analysis of biological specimens | |
| EA201590488A1 (ru) | Способы модификации клеток-хозяев | |
| IN2015DN01300A (enExample) | ||
| WO2015196130A3 (en) | Alternative nucleic acid molecules and uses thereof | |
| UA116205C2 (uk) | Спосіб кількісного визначення послідовності нуклеїнової кислоти в зразку | |
| EP3161162A4 (en) | Analysis of nucleic acid sequences | |
| EP3161160A4 (en) | Methods of analyzing nucleic acids from individual cells or cell populations | |
| AU2011356210A8 (en) | Novel fucosyltransferases and their applications | |
| EA201690529A1 (ru) | Способы модификации клетки-хозяина | |
| GB201205769D0 (en) | Methods for preparing samples for nucleic acid amplification | |
| MX2021013104A (es) | Variantes de lipasa y polinucleotidos que las codifican. | |
| PH12012000185A1 (en) | Detection of pathogens | |
| IN2014MN01989A (enExample) | ||
| GB2542576A (en) | Method and kit of detecting the absence of micro-oranisms | |
| WO2014145870A3 (en) | Novel compositions, methods and kits for blood typing | |
| IN2014CN03187A (enExample) | ||
| MX2018005872A (es) | Profarmacos de acido nucleico. | |
| MX370616B (es) | Amplificacion de acidos nucleicos. | |
| MX366113B (es) | Metodos de diganostico y composiciones. | |
| MX369054B (es) | Detección de moléculas de ácido nucleico. |